Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US sPMA for DJO's bone products:

This article was originally published in Clinica

Executive Summary

DJO has received FDA approval for a PMA supplement covering several new features built into its combined magnetic field (CMF) OL1000 and SpinaLogic bone growth stimulation product lines. The devices employ the San Diego, California firm's CMF technology, which it claims is the only waveform clinically proven to stimulate bone growth. The technology is indicated for use in aiding the healing of fractures in both long bone and primary lumbar spine applications. The new CMF OL1000 and SpinaLogic products are slated for launch in international markets in September.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049554

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel